Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above

To evaluate the immunogenicity of the investigational product (IP) in healthy adults aged 50 years or older and to explore differences in immune responses between the experimental and control groups, and to determine the optimal dose of the IP.

Participants needed: 135
Trial details
Phase: Phase 2Age: 50+Biological sex: AllType: InterventionalSponsor: CHA Vaccine Institute Co., Ltd.Updated: Mar 19, 2026Locations: 7
Eligibility criteria

Healthy adults aged 50 years or older [+3]

History of herpes zoster prior to screening [+7]

Status: Recruiting

Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above

The purpose of this study is to evaluate the safety and immunogenicity of the investigational medicinal product, CVI-VZV-001.

Participants needed: 32
Trial details
Phase: Phase 1Age: 50-64Biological sex: AllType: InterventionalSponsor: CHA Vaccine Institute Co., Ltd.Updated: Nov 19, 2024Locations: 2
Eligibility criteria

Healthy adults over 50 years old and under 65 years old [+3]

Those with a past history of shingles before screening [+22]